Company Overview

Company name: Surterra (Drug Discovery Platform)
Description: Developer of a drug discovery platform designed to offer safe, natural and consistent cannabis products. The company’s platform unlocks the natural health benefits of cannabis-based ingredients as well as cultivates, extracts and dispenses approved medical marijuana, enabling physicians to prescribe medicine to patients that provide a consistent result.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.surterra.com
Employees: 51
City: Atlanta
State: Georgia
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 164.43
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $54.63 million of convertible debt financing from undisclosed investors on October 31, 2018. Prior to that, the company received $65 million of Series C financing from Wychwood Asset Management on August 6, 2018. The company plans on using the funds across a number of strategic initiatives in Florida and Texas.company received $65 million of Series C financing from Wychwood Asset Management on August 6, 2018. The company plans on using the funds across a number of strategic initiatives in Florida and Texas.
Number of active investors:
Profile last updated: 02-Nov-2018
Last known valuation: 200.00
Last known valuation date: 06-Aug-2018